Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

[The value of plasma antiretroviral drug monitoring in the management of HIV infected patients].

Tréluyer JM.

Ann Med Interne (Paris). 2000 Jun;151(4):291-6. Review. French.

PMID:
10922957
3.

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.

Justesen US.

Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):20-31. Review.

4.
5.

Pharmacology considerations for antiretroviral therapy in human immunodeficiency virus (HIV)-infected children.

Hoody DW, Fletcher CV.

Semin Pediatr Infect Dis. 2003 Oct;14(4):286-94. Review.

PMID:
14724793
6.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
7.

Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection.

Back DJ, Khoo SH, Gibbons SE, Barry MG, Merry C.

Ther Drug Monit. 2000 Feb;22(1):122-6. Review.

PMID:
10688274
8.

Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?

Ribera E, López-Cortés LF, Soriano V, Casado JL, Mallolas J.

Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:41-67. Review. English, Spanish.

PMID:
16373004
9.

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.

Clevenbergh P, Mouly S, Sellier P, Badsi E, Cervoni J, Vincent V, Trout H, Bergmann JF.

Curr HIV Res. 2004 Oct;2(4):309-21. Review.

PMID:
15544452
10.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Feldman KA, Kennedy GE.

Cochrane Database Syst Rev. 2000;(2):CD002037. Review. Update in: Cochrane Database Syst Rev. 2003;(4):CD002037.

PMID:
10796850
11.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
12.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
13.

Therapeutic drug monitoring in the treatment of HIV-infection.

Gerber JG, Acosta EP.

J Clin Virol. 2003 Jul;27(2):117-28. Review.

PMID:
12829033
14.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Sangani PR, Kennedy GE.

Cochrane Database Syst Rev. 2003;(4):CD002037. Review.

PMID:
14583945
15.

Pharmacological considerations in antiretroviral therapy.

Sommadossi JP.

Antivir Ther. 1998;3 Suppl 4:9-12. Review.

PMID:
10723503
16.
17.
18.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
19.

[Antiretroviral resistance in human immunodeficiency virus infection].

Afani S A, Gallardo O AM.

Rev Chilena Infectol. 2011 Oct;28(5):461-9. doi: /S0716-10182011000600011. Epub 2011 Oct 19. Review. Spanish.

20.

Antiretroviral drug-drug interaction considerations for HIV-infected children.

Fletcher CV.

Pediatr Infect Dis J. 2009 May;28(5):429-30. doi: 10.1097/INF.0b013e3181a622bb. Review. No abstract available.

PMID:
19395949

Supplemental Content

Support Center